Dr. Reid is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3855 Health Sciences Dr
La Jolla, CA 92093Fax+1 619-543-7277
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1997 - 1999
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1991 - 1994
- Stanford University School of MedicineClass of 1991
Certifications & Licensure
- CA State Medical License 1993 - 2026
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- Top Doctors:San Diego Area Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2009-2013
- Join now to see all
Clinical Trials
- Clinical Trial in Patients With Metastatic Colorectal Cancer Start of enrollment: 2004 Apr 01
- A Study of Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the Liver Start of enrollment: 2010 Jan 01
- Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer Start of enrollment: 2011 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Lost at SCLC: a review of potential platinum sensitizers.Bryan Oronsky, Nacer Abrouk, Li Mao, Yunle Shen, Xiaohui Wang
Cancer Metastasis Reviews. 2024-12-01 - TGF-β trap of AdAPT-001 turns up the heat on tumors and turns down checkpoint blocker resistance.Tony R Reid, Bryan Oronsky, Jeannie Williams, Scott Caroen, Anthony Conley
Journal for Immunotherapy of Cancer. 2024-10-26 - CAR expression in invasive breast carcinoma and its effect on adenovirus transduction efficiency.Abraham T Phung, Jaimin R Shah, Tao Dong, Tony Reid, Christopher Larson
Breast Cancer Research. 2024-09-10
Press Mentions
- EpicentRx Doses First Subject in Phase III Lung Cancer Trial in ChinaOctober 7th, 2022
- • News - Full StoryJuly 12th, 2022
- New Phase 1 Clinical Trial for Pediatric CNS TumorsFebruary 24th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: